A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis

NCT06035354 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: AK120
DRUG: AK120
DRUG: Placebo
DRUG: AK120
DRUG: AK120
DRUG: AK120
DRUG: Placebo
DRUG: AK120
DRUG: AK120
DRUG: AK120

Sponsor

Akeso